{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:09:01Z","timestamp":1782126541141,"version":"3.54.5"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Cytomegalovirus (CMV) infection remains a critical cause of mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT), despite improvement by pre-emptive antivirus treatment. CMV-specific cytotoxic T lymphocytes (CMV-CTL) are universally used and proven well-tolerance after allo-HSCT in adult clinical trials. However, it is not comprehensively evaluated in children\u2019s patients. Herein, we conducted a retrospective study to determine the risk factors of CMV infection and evaluation of CMV-CTL in children patients who underwent allo-HSCT. As result, a significantly poor 5-year overall survival was found in the CMV infection group (87.3 vs. 94.6%, p=0.01). Haploidentical HSCT (haplo-HSCT) was identified as an independent risk factor for CMV infection through both univariate and multivariate analyses (p&amp;lt;0.001, p=0.027, respectively). Furthermore, the cumulative incidence of CMV infection was statistically higher in the haplo-HSCT group compared to the HLA-matched donor group (44.2% vs. 21.6%, p&amp;lt;0.001). Finally, the overall response rate of CMV-CTL was 89.7% (26\/29 patients) in CMV infection after allo-HSCT. We concluded that CMV infection following allo-HSCT correlated with increased mortality in children\u2019s patients, and haplo-HSCT was an independent risk factor for CMV infection. Adoptive CMV-CTL cell therapy was safe and effective in pediatric patients with CMV infection.<\/jats:p>","DOI":"10.3389\/fcimb.2022.1027341","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T07:26:02Z","timestamp":1666250762000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Features of cytomegalovirus infection and evaluation of cytomegalovirus-specific T cells therapy in children\u2019s patients following allogeneic hematopoietic stem cell transplantation: A retrospective single-center study"],"prefix":"10.3389","volume":"12","author":[{"given":"Yongsheng","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiujun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyun","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1182\/bloodadvances.2021005885","article-title":"Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease","volume":"6","author":"Akahoshi","year":"2022","journal-title":"Blood Adv."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14324","article-title":"Risk factors and incidence of cytomegalovirus viremia and disease in pediatric patients with allogeneic hematopoietic stem cell transplantation: An 8-year single-center experience in Latin America","volume":"26","author":"Aristizabal","year":"2022","journal-title":"Pediatr. Transplant."},{"key":"B3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ajh.25993","article-title":"Haploidentical vs matched unrelated donor transplantation for acute myeloid leukemia in remission: A prospective comparative study","volume":"96","author":"Cho","year":"2021","journal-title":"Am. J. Hematol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"6551","DOI":"10.21873\/anticanres.12111","article-title":"Risk factors for cytomegalovirus infection after allogeneic hematopoietic cell transplantation in malignancies: Proposal for classification","volume":"37","author":"Dziedzic","year":"2017","journal-title":"Anticancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/sj.bmt.1705585","article-title":"Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation","volume":"39","author":"Ganepola","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1111\/ajt.15515","article-title":"Cytomegalovirus (CMV) infection and risk of mortality in allogeneic hematopoietic stem cell transplantation (Allo-HSCT): A systematic review, meta-analysis, and meta-regression analysis","volume":"19","author":"Gimenez","year":"2019","journal-title":"Am. J. Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"E297","DOI":"10.1002\/ajh.25969","article-title":"Long-term results of the NF-08-TM protocol in stem cell transplant for patients with thalassemia major: A multi-center large-sample study","volume":"95","author":"He","year":"2020","journal-title":"Am. J. Hematol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.bbmt.2015.09.006","article-title":"Effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia","volume":"22","author":"Inagaki","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/s41409-020-01121-9","article-title":"Efficacy of low dose antithymocyte globulin on overall survival, relapse rate, and infectious complications following allogeneic peripheral blood stem cell transplantation for leukemia in children","volume":"56","author":"Kang","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1182\/blood-2019-129697","article-title":"Complementary transplantation improved results of both peripheral blood stem cells and unrelated cord blood transplants in thalassemia: A multi-center study from China","volume":"134","author":"Li","year":"2019","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13096","article-title":"Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia","volume":"21","author":"Lin","year":"2019","journal-title":"Transpl Infect. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1182\/blood-2012-03-417998","article-title":"A novel conditioning regimen improves outcomes in beta-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation","volume":"120","author":"Li","year":"2012","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13045-021-01065-7","article-title":"Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the acute leukemia working party of the European society for blood and marrow transplantation","volume":"14","author":"Nagler","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/bmt.2016.17","article-title":"Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections","volume":"51","author":"O'Reilly","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"B17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41423-021-00829-y","article-title":"Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantation","volume":"19","author":"Pei","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/infdis\/jix357","article-title":"Cytomegalovirus-specific T-cell transfer for refractory cytomegalovirus infection after haploidentical stem cell transplantation: The quantitative and qualitative immune recovery for cytomegalovirus","volume":"216","author":"Pei","year":"2017","journal-title":"J. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/ejh.13289","article-title":"Immune recovery after in vivo T-cell depletion myeloablative conditioning hematopoietic stem cell transplantation in severe beta-thalassemia children","volume":"103","author":"Qin","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.bbmt.2016.04.004","article-title":"Cytomegalovirus infection in pediatric hematopoietic stem cell transplantation: Risk factors for primary infection and cases of recurrent and late infection at a single center","volume":"22","author":"Rowe","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.865170","article-title":"Features of Epstein-Barr virus and cytomegalovirus reactivation in acute leukemia patients after haplo-HCT with myeloablative ATG-containing conditioning regimen","volume":"12","author":"Ru","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1182\/blood-2013-05-499830","article-title":"CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT","volume":"122","author":"Schmidt-Hieber","year":"2013","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01694","article-title":"Cellular therapeutic approaches to cytomegalovirus infection following allogeneic stem cell transplantation","volume":"11","author":"Shafat","year":"2020","journal-title":"Front. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/ajt.16147","article-title":"Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish hematopoietic transplantation and cell therapy group","volume":"21","author":"Solano","year":"2021","journal-title":"Am. J. Transplant."},{"key":"B25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11908-019-0699-0","article-title":"CMV prevention and treatment in transplantation: What's new in 2019","volume":"21","author":"Stern","year":"2019","journal-title":"Curr. Infect. Dis. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.bbmt.2015.07.019","article-title":"Cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation is associated with a reduced risk of relapse in patients with acute myeloid leukemia who survived to day 100 after transplantation: The Japan society for hematopoietic cell transplantation transplantation-related complication working group","volume":"21","author":"Takenaka","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1182\/bloodadvances.2021005509","article-title":"Impact of CMV reactivation on relapse of acute myeloid leukemia after HCT is dependent on disease stage and ATG","volume":"6","author":"Turki","year":"2022","journal-title":"Blood Adv."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/j.bbmt.2018.03.028","article-title":"Control of cytomegalovirus viremia after allogeneic stem cell transplantation: A review on CMV-specific T cell reconstitution","volume":"24","author":"van der Heiden","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13893","article-title":"Augmented immunosuppression and PTCY-based haploidentical hematopoietic stem cell transplantation for thalassemia major","volume":"25","author":"Vellaichamy Swaminathan","year":"2021","journal-title":"Pediatr. Transplant."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.bbmt.2007.06.006","article-title":"Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources","volume":"13","author":"Walker","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B31","doi-asserted-by":"publisher","first-page":"332.e1","DOI":"10.1016\/j.jtct.2022.03.018","article-title":"Optimal active anti-thymocyte globulin exposure associated with minimum risk of virus reactivation and comparable acute graft-Versus-Host disease under adult myeloablative haploidentical peripheral blood stem cell transplantation","volume":"28","author":"Wang","year":"2022","journal-title":"Transplant. Cell Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/16078454.2022.2038402","article-title":"Encouraging the outcomes of children with beta-thalassaemia major who underwent fresh cord blood transplantation from an HLA-matched sibling donor","volume":"27","author":"Wen","year":"2022","journal-title":"Hematology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1182\/blood-2021-150888","article-title":"Post transplantation fludarabine and cyclophosphamide selected and promoted low dose of unrelated UCB implanation in combined transplantation of haploid and UCB stem cells in childhood leukemia: 40 cases report in double center","volume":"138","author":"Xiao","year":"2021","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/s41409-018-0369-0","article-title":"Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation","volume":"54","author":"Yokoyama","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.bbmt.2020.04.002","article-title":"Favorable effect of cytomegalovirus reactivation on outcomes in cord blood transplant and its differences among disease risk or type","volume":"26","author":"Yokoyama","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/cid\/ciz368","article-title":"First-line therapy with donor-derived human cytomegalovirus (HCMV)-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation","volume":"70","author":"Zhao","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1002\/sctm.20-0495","article-title":"Umbilical cord blood transplantation: Still growing and improving","volume":"10","author":"Zhu","year":"2021","journal-title":"Stem Cells Transl. Med."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1027341\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T07:26:05Z","timestamp":1666250765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1027341\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":37,"alternative-id":["10.3389\/fcimb.2022.1027341"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.1027341","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"article-number":"1027341"}}